Aditxt, Inc. (NASDAQ:ADTX) Short Interest Down 45.2% in December

Aditxt, Inc. (NASDAQ:ADTX) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 99,100 shares, a decline of 45.2% from the November 30th total of 180,800 shares. Based on an average daily volume of 3,270,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.7% of the company’s stock are short sold.

Aditxt Stock Down 2.3 %

Shares of ADTX opened at $0.19 on Friday. The company has a 50 day moving average of $0.41 and a 200-day moving average of $24.44. Aditxt has a twelve month low of $0.18 and a twelve month high of $338.80.

Insider Activity

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of the stock in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total transaction of $29,874.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.72% of the company’s stock.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.